193 related articles for article (PubMed ID: 31658997)
21. HDAC5 Inhibits Hepatic Lipogenic Genes Expression by Attenuating the Transcriptional Activity of Liver X Receptor.
Jia HY; Li QZ; Lv LF
Cell Physiol Biochem; 2016; 39(4):1561-7. PubMed ID: 27614433
[TBL] [Abstract][Full Text] [Related]
22. The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.
Hammer SS; Beli E; Kady N; Wang Q; Wood K; Lydic TA; Malek G; Saban DR; Wang XX; Hazra S; Levi M; Busik JV; Grant MB
EBioMedicine; 2017 Aug; 22():181-190. PubMed ID: 28774737
[TBL] [Abstract][Full Text] [Related]
23. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
[TBL] [Abstract][Full Text] [Related]
24. [Research progress of the relationship between liver X receptor and inflammatory-related diseases].
Gao BC; Chen Q; Sun T; Wang DM; Xiao J
Sheng Li Xue Bao; 2018 Jun; 70(3):335-341. PubMed ID: 29926076
[TBL] [Abstract][Full Text] [Related]
25. The Peroxisome Proliferator-Activated Receptor (PPAR)-
Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
[TBL] [Abstract][Full Text] [Related]
26. Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages.
Wei Z; Wang J; Shi M; Liu W; Yang Z; Fu Y
Oncotarget; 2016 Aug; 7(31):48995-49007. PubMed ID: 27285988
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
[TBL] [Abstract][Full Text] [Related]
28. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
29. Cinnamamides, Novel Liver X Receptor Antagonists that Inhibit Ligand-Induced Lipogenesis and Fatty Liver.
Sim WC; Kim DG; Lee KJ; Choi YJ; Choi YJ; Shin KJ; Jun DW; Park SJ; Park HJ; Kim J; Oh WK; Lee BH
J Pharmacol Exp Ther; 2015 Dec; 355(3):362-9. PubMed ID: 26384859
[TBL] [Abstract][Full Text] [Related]
30. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
[TBL] [Abstract][Full Text] [Related]
31. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.
Ning Y; Bai Q; Lu H; Li X; Pandak WM; Zhao F; Chen S; Ren S; Yin L
Atherosclerosis; 2009 May; 204(1):114-20. PubMed ID: 18945429
[TBL] [Abstract][Full Text] [Related]
33. HSP70 induces liver X receptor pathway activation and cholesterol reduction in vitro and in vivo.
Gungor B; Vanharanta L; Hölttä-Vuori M; Pirhonen J; Petersen NHT; Gramolelli S; Ojala PM; Kirkegaard T; Ikonen E
Mol Metab; 2019 Oct; 28():135-143. PubMed ID: 31327756
[TBL] [Abstract][Full Text] [Related]
34. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
Bensinger SJ; Tontonoz P
Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis.
Zhong S; Zhao L; Li Q; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Inflammation; 2015; 38(3):959-71. PubMed ID: 25387652
[TBL] [Abstract][Full Text] [Related]
36. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
37. miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.
Ouimet M; Hennessy EJ; van Solingen C; Koelwyn GJ; Hussein MA; Ramkhelawon B; Rayner KJ; Temel RE; Perisic L; Hedin U; Maegdefessel L; Garabedian MJ; Holdt LM; Teupser D; Moore KJ
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):942-951. PubMed ID: 26941018
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
[TBL] [Abstract][Full Text] [Related]
39. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.
Zhang L; Jiang M; Shui Y; Chen Y; Wang Q; Hu W; Ma X; Li X; Liu X; Cao X; Liu M; Duan Y; Han J
Biochim Biophys Acta; 2013 Jun; 1831(6):1134-45. PubMed ID: 23466610
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response.
Ou X; Gao JH; He LH; Yu XH; Wang G; Zou J; Zhao ZW; Zhang DW; Zhou ZJ; Tang CK
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158535. PubMed ID: 31678621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
